EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Therapie, 68 2 (2013) 69-76 Article's citations

Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Case report: Spontaneous splenic rupture concomitant with serum sickness induced by infliximab

Thomas Darque, Arthur Dubernet, Chloé Martineau, Julia Goossens, Marie-Laure Jullie and Nathalie Sultan
Therapies (2025)
https://doi.org/10.1016/j.therap.2025.04.004

Encephalopathy associated with equimolar mixture of oxygen and nitrous oxide (EMONO) abuse: A case report

Nathan Pierrat-Maury, Serghei Banari, Tanguy Taillefer de Laportalière, Anne Roussin, Louis Richaud, Etienne Very and François Montastruc
Therapies (2025)
https://doi.org/10.1016/j.therap.2025.02.005

Photodistributed cutaneous vasculitis: An uncommon side effect for topical ketoprofen

Nadia Fetoui Ghariani, Nour el Imene Ouni, Sawssen Layouni, Marwa Thabouti, Haifa Mkhinini, Maha Lahouel, Badreddine Sriha, Ben Salem C., Najet Ghariani and Mohamed Denguezli
Therapies (2025)
https://doi.org/10.1016/j.therap.2025.01.003

Can large language models detect drug–drug interactions leading to adverse drug reactions?

Justine Sicard, François Montastruc, Coline Achalme, Annie Pierre Jonville-Bera, Paul Songue, Marina Babin, Thomas Soeiro, Pauline Schiro, Claire de Canecaude and Romain Barus
Therapeutic Advances in Drug Safety 16 (2025)
https://doi.org/10.1177/20420986251339358

Dapagliflozin-induced leukocytoclastic vasculitis

Dhouha Sahnoun, Houda Ghardallou, Myriam Agrebi, Mohamed Ben Rejeb, Najet Ghariani, Badreddine Sriha, Mohamed Denguezli and Chaker Ben Salem
Therapies 80 (3) 336 (2025)
https://doi.org/10.1016/j.therap.2024.06.004

Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention

Maxime Villiet, Marion Laureau, Damien Perier, et al.
JAMA Internal Medicine 185 (6) 669 (2025)
https://doi.org/10.1001/jamainternmed.2025.0640

Evaluation of the reproducibility and validity of the use of the causality assessment method for poisonings designed and applied by the French poison control centres

Sandra Sinno-Tellier, Dorian Délepine, Dominique Vodovar, Coralie Bragança, Marie Sponga, Emmanuel Puskarczyk, Ingrid Blanc-Brisset, Fanny Pelissier, Ismaïl Ahmed, Jacques Manel, Juliette Bloch and Alexis Descatha
Clinical Toxicology 1 (2025)
https://doi.org/10.1080/15563650.2025.2515239

Patch tests in non‐immediate cutaneous adverse drug reactions: Late readings on Day 4 is more sensitive than on Day 3

Ilaria Matei, Thomas Bettuzzi, Amandine Weill, Gwendeline Gener, Kamar Bel Hareth, Fleck Margaux, Muriel Verlinde‐Carvalho, Muriel Paul, Saskia Ingen‐Housz‐Oro and Haudrey Assier
Contact Dermatitis 91 (4) 321 (2024)
https://doi.org/10.1111/cod.14654

Drug-related hypophosphatemia: Descriptive study and case/non-case analysis of the French national pharmacovigilance database

Eve-Marie Thillard, Paula Sade, Joelle Michot, Virginie Bres and Annie-Pierre Jonville-Bera
Therapies 79 (3) 371 (2024)
https://doi.org/10.1016/j.therap.2023.07.007

Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database

Yu Rim Kim, Ji Hyeon Kim, Sang Won Kim, Jae Min Lee and Jacob S. Bae
Journal of Clinical Medicine 13 (4) 1159 (2024)
https://doi.org/10.3390/jcm13041159

Disseminated Mycobacterial Infection With Reactive Polyarthritis (Poncet’s Disease) During Immune-suppressive Treatment Including Ustekinumab for Pediatric Crohn’s Disease

Chiara Minotti, Paola Costenaro, Daniele Donà, Monica Zuliani, Luca Bosa, Alberta Leon, Giorgio Perilongo, Paola Gaio, Giorgia Martini and Mara Cananzi
Pediatric Infectious Disease Journal 43 (6) 543 (2024)
https://doi.org/10.1097/INF.0000000000004277

BABINE: An original and user-friendly scale for the simple and quick management of herb-drug interactions in clinical practice

Anthony Cnudde, Camille Allely, Natacha Biset, Pierre Champy, Nathalie Fouilhé, Fanny Huret, Sibi Lawson, Aline Mercan, Doris Pascale Noukela Noumi, Serge Michalet, Andrea Montis, Stephanie Pochet, Audrey Schils, Cecilia Tangeten, Michel Tod, Pierre Van Antwerpen, Audrey Vervacke and Florence Souard
BMC Complementary Medicine and Therapies 24 (1) (2024)
https://doi.org/10.1186/s12906-024-04706-9

Drug-Induced Uveitis Related to Checkpoint Inhibitors and MAP-kinase Inhibitors

Thomas Thibault, Inès Ben Ghezala, Romane Freppel, Abdessamad Rajillah, Charlène Boulay, Pierre Brunel, Marina Atzenhoffer, Clément Auvens, Hervé Devilliers and Aurélie Grandvuillemin
Ophthalmology 131 (2) 249 (2024)
https://doi.org/10.1016/j.ophtha.2023.10.004

Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD

Solène M. Laville, Valérie Gras-Champel, Aghilès Hamroun, Julien Moragny, Oriane Lambert, Marie Metzger, Christian Jacquelinet, Christian Combe, Denis Fouque, Maurice Laville, Luc Frimat, Bruce M. Robinson, Brian Bieber, Bénédicte Stengel, Natalia Alencar De Pinho, Ziad A. Massy, Sophie Liabeuf, Carole Ayav, Serge Briançon, Dorothée Cannet, Christian Combe, Denis Fouque, Luc Frimat, Yves-Edouard Herpe, Christian Jacquelinet, et al.
American Journal of Kidney Diseases 83 (5) 601 (2024)
https://doi.org/10.1053/j.ajkd.2023.09.012

An Uncommon Case of DRESS Syndrome Induced by Potaba With a Positive Patch Test

Yasmine Salem Mahjoubi, Imen Hamza, Ghozlane Lakhoua, Ons Charfi, Ahmed Zaiem, Sarah Kastalli and Sihem El Aidli
American Journal of Therapeutics 31 (5) e600 (2024)
https://doi.org/10.1097/MJT.0000000000001745

Terbinafine induced bullous pemphigoid

Khaoula Trimeche, Ines Lahouel, Nesrine Ben salah, Khadija Mansour, Yosra Soua, Ahlem Bellalah, Zohra Chadly, Hichem Belhadjali and Jameleddine Zili
Therapies 79 (4) 488 (2024)
https://doi.org/10.1016/j.therap.2023.12.005

Carbamazepine-induced bullous fixed drug eruption: A case report

Amal Habchane, Fadwa Bentabet, Soukaina Khatem, Ayyoub Alioua, Imane Adali, Fatiha Manoudi and Sanaa Zaoui
Therapies 79 (4) 477 (2024)
https://doi.org/10.1016/j.therap.2023.09.002

Acute generalized exanthematous pustulosis: Analysis of cases managed in a Tunisian tertiary hospital

Neila Fathallah, Zied Kenani, Sana Mokni, Ryma Gammoudi, Raoudha Slim, Nadia Fetoui Ghariani, Najet Ghariani, Chaker Ben Salem, Bouraoui Ouni and Mohamed Denguezli
Therapies 79 (4) 469 (2024)
https://doi.org/10.1016/j.therap.2023.11.011

Nivolumab Safety in Renal Cell Carcinoma: A Case Report

James Debono, Dustin Balzan, John Joseph Borg, Stephen Falzon, Dania al-Haddad, Benjamin Micallef and Janet Sultana
Journal of Pharmacy Technology 40 (2) 112 (2024)
https://doi.org/10.1177/87551225231218164

Acute stroke in patients taking an oral anticoagulant: impact of clinical pharmacist’s intervention on pharmacovigilance reporting

Eve-Marie Thillard, Chloé Rousselière, Johana Béné, François Caparros, Marie Bodenant, Pascal Odou, Sophie Gautier and Bertrand Décaudin
Acta Clinica Belgica 78 (6) 478 (2023)
https://doi.org/10.1080/17843286.2023.2261716

Involvement of Pharmacists in the Emergency Department to Correct Errors in the Medication History and the Impact on Adverse Drug Event Detection

Clara Goulas, Laura Lohan, Marion Laureau, Damien Perier, Véronique Pinzani, Marie Faucanie, Valérie Macioce, Grégory Marin, Isabelle Giraud, Maxime Villiet, Mustapha Sebbane and Cyril Breuker
Journal of Clinical Medicine 12 (1) 376 (2023)
https://doi.org/10.3390/jcm12010376

Acute generalized exanthematous pustulosis induced by duloxetine

Numa Deydier, Hélène Jantzem, Zarrin Alavi, Glen Le Flahec, Marine Robert, Anne‐Marie Roguedas‐Contios, Emilie Brenaut, Laurent Misery and Greta Gourier
JEADV Clinical Practice 2 (2) 363 (2023)
https://doi.org/10.1002/jvc2.138

Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis

Annette Haerdtlein, Elisabeth Debold, Marietta Rottenkolber, Anna Maria Boehmer, Yvonne Marina Pudritz, Faiza Shahid, Jochen Gensichen and Tobias Dreischulte
Journal of Clinical Medicine 12 (4) 1320 (2023)
https://doi.org/10.3390/jcm12041320

Shortcomings of Administrative Data to Derive Preventive Strategies for Inhospital Drug-Induced Acute Kidney Failure—Insights from Patient Record Analysis

Stefanie Amelung, David Czock, Markus Thalheimer, Torsten Hoppe-Tichy, Walter E. Haefeli and Hanna M. Seidling
Journal of Clinical Medicine 11 (15) 4285 (2022)
https://doi.org/10.3390/jcm11154285

Idiopathic non-cirrhotic portal hypertension (INCPH) during azathioprine treatment in patient with Crohn's disease: A case report

Khaoula Chabbouh, Douha Cherif, Habiba Debbabi, Hela Kchir, Hejer Hassine, Syrine Ben-Hammamia, Ghozlane Lakhoua, Abdelkader Jarray, Wassim Frikha, Beya Chelly, Sihem El-Aidli, Habiba Mizouni, Slim Haouet and Nadia Maamouri
Therapies 77 (4) 489 (2022)
https://doi.org/10.1016/j.therap.2021.07.001

Frequency, Characteristics, and Predictive Factors of Adverse Drug Events in an Adult Emergency Department according to Age: A Cross-Sectional Study

Laura Lohan, Grégory Marin, Marie Faucanie, Marion Laureau, Damien Perier, Véronique Pinzani, Isabelle Giraud, Maxime Villiet, Mustapha Sebbane, Ariane Sultan and Cyril Breuker
Journal of Clinical Medicine 11 (19) 5731 (2022)
https://doi.org/10.3390/jcm11195731

Patch tests in nonimmediate cutaneous adverse drug reactions: The importance of late readings on day 4

Zoé Bhujoo, Saskia Ingen‐Housz‐Oro, Gwendeline Gener, Olivier Gaudin, Margaux Fleck, Muriel Verlinde‐Carvalho, Muriel Paul, Olivier Chosidow, Paul Wolkenstein and Haudrey Assier
Contact Dermatitis 86 (1) 29 (2022)
https://doi.org/10.1111/cod.13981

Bullous haemorrhagic dermatitis induced by heparins and other anticoagulants: 94 cases from French pharmacovigilance centres and a literature review

M. Uceda-Martin, A. Lambert, G. Miremont, A. Gaiffe, M.-S. Agier, M. Studer, A. Mahé, M. Tebacher and B. Cribier
Annales de Dermatologie et de Vénéréologie 149 (1) 45 (2022)
https://doi.org/10.1016/j.annder.2021.05.003

Beware of Rhabdomyolysis After a Renal Graft

Ghita El Bardai, Basmat Amal Chouhani, Widad Haddane, Nadia Kabbali and Tarik Sqalli Houssaini
Cureus (2022)
https://doi.org/10.7759/cureus.30546

Prise en charge des toxidermies graves induites par les antidépresseurs et les antipsychotiques. Comment les prendre en charge ?

A. Weill, A. Olry, L. Thomas, K. Zaghbib, H. Assier and S. Ingen-Housz-Oro
Annales de Dermatologie et de Vénéréologie - FMC 2 (4) 340 (2022)
https://doi.org/10.1016/j.fander.2021.11.006

Potential cytochrome P450-mediated pharmacokinetic interactions between herbs, food, and dietary supplements and cancer treatments

Paul Gougis, Marc Hilmi, Arthur Geraud, Olivier Mir and Christian Funck-Brentano
Critical Reviews in Oncology/Hematology 166 103342 (2021)
https://doi.org/10.1016/j.critrevonc.2021.103342

Impact of medication characteristics and adverse drug events on hospital admission after an emergency department visit: Prospective cohort study

Laura Lohan, Gregory Marin, Marie Faucanie, Marion Laureau, Valérie Macioce, Damien Perier, Veronique Pinzani, Isabelle Giraud, Audrey Castet‐Nicolas, Anne Jalabert, Maxime Villiet, Mustapha Sebbane and Cyril Breuker
International Journal of Clinical Practice 75 (7) (2021)
https://doi.org/10.1111/ijcp.14224

Indication et réalisation des tests allergologiques dans les hypersensibilités retardées médicamenteuses de l’adulte

H. Assier, G. Gener and C. Bernier
Annales de Dermatologie et de Vénéréologie - FMC 1 (1) 35 (2021)
https://doi.org/10.1016/j.fander.2020.07.001

Serious Neurological Adverse Events of Ceftriaxone

Clémence Lacroix, Annie-Pierre Bera-Jonville, François Montastruc, Lionel Velly, Joëlle Micallef and Romain Guilhaumou
Antibiotics 10 (5) 540 (2021)
https://doi.org/10.3390/antibiotics10050540

Adverse Drug Events Detected by Clinical Pharmacists in an Emergency Department: A Prospective Monocentric Observational Study

Marion Laureau, Olivier Vuillot, Vincent Gourhant, Damien Perier, Véronique Pinzani, Laura Lohan, Marie Faucanie, Valérie Macioce, Grégory Marin, Isabelle Giraud, Anne Jalabert, Maxime Villiet, Audrey Castet-Nicolas, Mustapha Sebbane and Cyril Breuker
Journal of Patient Safety 17 (8) e1040 (2021)
https://doi.org/10.1097/PTS.0000000000000679

Preconceived notions about biosimilars—a French experience

Jean-David Cohen, Sonia Tropé, Pascal Paubel, Audrey Munos and François Bocquet
Clinical Rheumatology 39 (8) 2251 (2020)
https://doi.org/10.1007/s10067-020-05229-7

Acute exanthemas: a prospective study of 98 adult patients with an emphasis on cytokinic and metagenomic investigation

O. Deschamps, N. Ortonne, S. Hüe, et al.
British Journal of Dermatology 182 (2) 355 (2020)
https://doi.org/10.1111/bjd.18166

Severe poisoning with naproxen causing coagulopathy

Bénédicte Lelièvre, Isabelle Drouillard, Chloé Thill, Gaël Le Roux, Chloé Bruneau, Julien Mahé, Marie Deguigne and David Boels
Basic & Clinical Pharmacology & Toxicology 126 (5) 458 (2020)
https://doi.org/10.1111/bcpt.13365

Immediate-Type Hypersensitivity Cross-Reactions to Proton Pump Inhibitors: A Descriptive Study of Data from the French National Pharmacovigilance Database

Caroline Tourillon, Julien Mahe, Aurélie Baron, Aude Lambert, Mélissa Yélehé-Okouma, Gwenaelle Veyrac and Pascale Jolliet
International Archives of Allergy and Immunology 178 (2) 159 (2019)
https://doi.org/10.1159/000493581

Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases

Bethsabée Garel, Saskia Ingen‐Housz‐Oro, Daniele Afriat, Catherine Prost‐Squarcioni, Florence Tétart, Benoit Bensaid, Corina Bara Passot, Marie Beylot‐Barry, Vincent Descamps, Sophie Duvert‐Lehembre, Sabine Grootenboer‐Mignot, Géraldine Jeudy, Angèle Soria, Marie Blanche Valnet‐Rabier, Annick Barbaud, Frédéric Caux and Bénédicte Lebrun‐Vignes
British Journal of Clinical Pharmacology 85 (3) 570 (2019)
https://doi.org/10.1111/bcp.13827

Hypersensibilité retardée aux traitements antituberculeux. Proposition d’une conduite à tenir pratique devant un exanthème : quand arrêter, quelles explorations allergologiques et comment réintroduire le traitement

S. Ingen-Housz-Oro, H. Assier, G. Gener, et al.
Annales de Dermatologie et de Vénéréologie 146 (4) 313 (2019)
https://doi.org/10.1016/j.annder.2019.01.010

Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia

Diaddin Hamdan, Christophe Leboeuf, Christine Le Foll, Guilhem Bousquet and Anne Janin
Cancer Medicine 8 (5) 2005 (2019)
https://doi.org/10.1002/cam4.2062

Prévalence des effets indésirables de l’hydroxychloroquine (Plaquenil ® ) dans une population dermatologique : étude rétrospective sur 102 patients

P. Tétu, A. Hamelin, B. Lebrun-Vignes, et al.
Annales de Dermatologie et de Vénéréologie 145 (6-7) 395 (2018)
https://doi.org/10.1016/j.annder.2018.03.168

Three case reports of involuntary muscular movements as adverse reactions to sacubitril/valsartan

Theodora Bejan‐Angoulvant, Thibaud Genet, Laura Vrignaud, Denis Angoulvant and Laurent Fauchier
British Journal of Clinical Pharmacology 84 (5) 1072 (2018)
https://doi.org/10.1111/bcp.13545

Polymyosite éosinophilique liée à l’utilisation du fébuxostat dans le traitement d’un lymphome de la zone marginale

Georges Chahine, Khalil Saleh, Claude Ghorra, et al.
Revue du Rhumatisme 84 (5) 453 (2017)
https://doi.org/10.1016/j.rhum.2017.04.001

Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting

Annamaria Mascolo, Cristina Scavone, Maurizio Sessa, et al.
Pharmacological Research 123 122 (2017)
https://doi.org/10.1016/j.phrs.2017.07.005

Cyamémazine (Tercian®) et syndromes extrapyramidaux : exploration des cas contenus dans la base nationale de pharmacovigilance

Charles Khouri, Marion Lepelley, Céline Villier, Thierry Bougerol and Michel Mallaret
Therapies 72 (3) 345 (2017)
https://doi.org/10.1016/j.therap.2016.07.004

Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir

Sébastien Renard, Patrick Borentain, Erwan Salaun, et al.
Chest 149 (3) e69 (2016)
https://doi.org/10.1016/j.chest.2015.09.018

Fatal Kounis syndrome with stent thrombosis secondary to amoxicillin/clavulanic acid use: A case report and literature review

Issam Salouage, Sihem El Aidli, Sarra Kastalli, Riadh Daghfous and Mohamed Lakhal
Therapies 71 (6) 535 (2016)
https://doi.org/10.1016/j.therap.2016.06.004

Imputabilité en pharmacovigilance : de la méthode française originelle aux méthodes réactualisées

Ghada Miremont-Salamé, Hélène Théophile, Françoise Haramburu and Bernard Bégaud
Therapies 71 (2) 171 (2016)
https://doi.org/10.1016/j.therap.2016.02.009

Causality assessment in pharmacovigilance: The French method and its successive updates

Ghada Miremont-Salamé, Hélène Théophile, Françoise Haramburu and Bernard Bégaud
Therapies 71 (2) 179 (2016)
https://doi.org/10.1016/j.therap.2016.02.010

Evaluación de la causalidad en las comunicaciones de reacciones adversas a medicamentos. Algoritmo del Sistema Español de Farmacovigilancia

Carmelo Aguirre and Montserrat García
Medicina Clínica 147 (10) 461 (2016)
https://doi.org/10.1016/j.medcli.2016.06.012

Can an early diagnostic procedure of metformin-associated lactic acidosis in an emergency unit reduce mortality?

Damien Sémely, Emily Bennett, Christine Vallejo, et al.
Therapies 71 (6) 605 (2016)
https://doi.org/10.1016/j.therap.2016.05.006

Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database

Jean-Baptiste Bossard, Camille Ponté, Julie Dupouy, Maryse Lapeyre-Mestre and Emilie Jouanjus
Clinical Drug Investigation 36 (9) 735 (2016)
https://doi.org/10.1007/s40261-016-0421-z

Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system

Carmelo Aguirre and Montserrat García
Medicina Clínica (English Edition) 147 (10) 461 (2016)
https://doi.org/10.1016/j.medcle.2016.12.007

The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project

Emanuel Raschi, Elisabetta Poluzzi, Francesco Salvo, et al.
Drug Safety 39 (1) 59 (2016)
https://doi.org/10.1007/s40264-015-0353-1

Quelle PharmacoVigilance pour les vaccins ?

Jean-Louis Montastruc, Geneviève Durrieu, Isabelle Lacroix, Maryse Lapeyre-Mestre, Christine Damase-Michel, Haleh Bagheri and Agnès Sommet
Bulletin de l'Académie Nationale de Médecine 200 (2) 241 (2016)
https://doi.org/10.1016/S0001-4079(19)30755-1

Development and Application of Network Toxicology in Safety Research of Chinese Materia Medica

Xing Zhang, Hui-rong Fan, Ya-zhuo Li, et al.
Chinese Herbal Medicines 7 (1) 27 (2015)
https://doi.org/10.1016/S1674-6384(15)60016-8

Réhospitalisations d’origine médicamenteuse : étude pilote dans un service de post-urgences médicales d’un hôpital universitaire français

H. Chayé, M. Bernard, M. Tubéry, et al.
La Revue de Médecine Interne 36 (7) 450 (2015)
https://doi.org/10.1016/j.revmed.2014.11.016

Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies

Hélène Théophile, Jean-Paul Dutertre, Marie Gérardin, et al.
Therapies 70 (5) 465 (2015)
https://doi.org/10.2515/therapie/2015028

Imiquimod and Pulmonary Embolism: a Case Report

Bertrand Leroy, Antoine Richez, François Wolf, Jacques Descotes and Thierry Vial
Therapies 69 (2) 180 (2014)
https://doi.org/10.2515/therapie/2013075